David Leopard is an associate at BFA and represents investors in securities class actions and related litigation. David is currently a member of the teams prosecuting securities class action cases against Five9, Inc., and Twist Bioscience Corp, as well as derivative claims involving BioVentrix, Inc.
Prior to joining BFA, David was an associate at a prominent law firm in New York for four years, where he was a member of the firm’s Securities and M&A Litigation Group. He also represented clients in connection with Delaware and derivative actions, white collar investigations, and complex commercial litigation. While earning his law degree from Boston College Law School, he worked as a legal intern in the Enforcement Division at the U.S. Commodity Futures Trading Commission.
| Case | Type | Status |
|---|---|---|
| Lucid Alternative Fund, LP v. Five9, Inc. et al. | U.S. Securities Litigation | Pending |
| Moline v. BioVentrix, Inc. | Corporate Governance | Pending |
| Peters v. Twist Bioscience Corp. et al. | U.S. Securities Litigation | Pending |